Xtal Concepts
Private Company
Funding information not available
Overview
Xtal Concepts is a privately-held instrumentation company serving the structural biology and biopharmaceutical research markets. Its core technology is the SpectroLight 600, a high-throughput dynamic light scattering (DLS) instrument that dramatically accelerates sample quality assessment and optimization for techniques like crystallography, cryo-EM, and SAXS. By enabling rapid analysis of monodispersity, aggregation, and size with minimal sample volume, the company addresses a key bottleneck in the drug discovery pipeline. Xtal Concepts appears to be in a revenue-generating stage, actively selling its instruments and showcasing them at major scientific conferences.
Technology Platform
High-throughput dynamic light scattering (DLS) instrumentation, specifically the SpectroLight 600, for characterizing nano- and microparticles in liquids. Enables rapid, low-volume sample analysis for optimizing conditions in structural biology techniques like crystallography, cryo-EM, and SAXS.
Opportunities
Risk Factors
Competitive Landscape
Operates in the biophysical characterization instrument market, competing directly with the DLS product lines of major players like Malvern Panalytical (Zetasizer) and Wyatt Technology (DynaPro). Differentiation is achieved through ultra-high-throughput design using microplates, minimal sample consumption, and a focused workflow for structural biology sample preparation.